18F-FDG PET and PET/CT in fever of unknown origin
J Meller, CO Sahlmann, AK Scheel - Journal of Nuclear Medicine, 2007 - Soc Nuclear Med
Fever of unknown origin (FUO) was originally defined as recurrent fever of 38.3C or higher,
lasting 2–3 wk or longer, and undiagnosed after 1 wk of hospital evaluation. The last criterion …
lasting 2–3 wk or longer, and undiagnosed after 1 wk of hospital evaluation. The last criterion …
Pelvic lymph node dissection for nodal oligometastatic prostate cancer detected by 68Ga‐PSMA‐positron emission tomography/computerized tomography
…, J Lotz, HU Schildhaus, L Trojan, CO Sahlmann - The …, 2015 - Wiley Online Library
BACKGROUND The first evaluation of pelvic extended lymph node dissection (pLND) in
oligometastatic prostate cancer (PCa) detected by 68 Ga‐PSMA PET/CT. METHODS …
oligometastatic prostate cancer (PCa) detected by 68 Ga‐PSMA PET/CT. METHODS …
[HTML][HTML] Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and …
B Meller, F Bremmer, CO Sahlmann, S Hijazi, C Bouter… - EJNMMI research, 2015 - Springer
Background Prostate-specific membrane antigen (PSMA) is a promising target for diagnostics
and therapy of prostate carcinoma (PCa). Based on the hypothesis that PSMA expression …
and therapy of prostate carcinoma (PCa). Based on the hypothesis that PSMA expression …
Biphasic 68Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma
CO Sahlmann, B Meller, C Bouter, CO Ritter… - European journal of …, 2016 - Springer
… Carsten-Oliver Sahlmann declares that he has no conflict of interest. Birgit Meller declares
that she has no conflict of interest. Caroline Bouter declares that she has no conflict of interest…
that she has no conflict of interest. Caroline Bouter declares that she has no conflict of interest…
[HTML][HTML] 18F-FDG-PET Detects Drastic Changes in Brain Metabolism in the Tg4–42 Model of Alzheimer's Disease
…, TN Franke, C Irwin, CO Sahlmann… - Frontiers in aging …, 2019 - frontiersin.org
The evaluation of new therapeutic strategies in Alzheimer’s disease (AD) relies heavily on
in vivo imaging and suitable animal models that mimic the pathological changes seen in …
in vivo imaging and suitable animal models that mimic the pathological changes seen in …
[HTML][HTML] The role of PSMA PET/CT in the primary diagnosis and follow-up of prostate cancer—a practical clinical review
…, A Strauß, B Meller, JA Bucerius, CO Sahlmann - Cancers, 2022 - mdpi.com
Simple Summary The combination of positron emission tomography (PET)-diagnostics with
ligands binding to the prostate-specific membrane antigen (PSMA) has been a diagnostic …
ligands binding to the prostate-specific membrane antigen (PSMA) has been a diagnostic …
[HTML][HTML] Enhancing PSMA-uptake with androgen deprivation therapy–a new way to detect prostate cancer metastases?
…, P Thelen, M Schmid, J Meller, CO Sahlmann… - International braz j …, 2019 - SciELO Brasil
SciELO - Brasil - Enhancing PSMA-uptake with androgen deprivation therapy – a new way
to detect prostate cancer metastases? Enhancing PSMA-uptake with androgen deprivation …
to detect prostate cancer metastases? Enhancing PSMA-uptake with androgen deprivation …
See the unseen: mesorectal lymph node metastases in prostate cancer
…, C Ritter, J Lotz, J Meller, L Trojan, CO Sahlmann - The …, 2016 - Wiley Online Library
BACKGROUND Our study is the first evaluation of nodal metastatic prostate cancer (PCa) to
mesorectal lymph nodes (MLN) detected by 68 Ga‐PSMA‐PET/CT. METHODS We …
mesorectal lymph nodes (MLN) detected by 68 Ga‐PSMA‐PET/CT. METHODS We …
Brain 18F‐FDG‐PET and an optimized cingulate island ratio to differentiate Lewy body dementia and Alzheimer's disease
K Woyk, CO Sahlmann, N Hansen… - Journal of …, 2023 - Wiley Online Library
Background and Purpose The diagnosis of Dementia with Lewy Bodies (DLB) is challenging
due to various clinical presentations and clinical and neuropathological features that …
due to various clinical presentations and clinical and neuropathological features that …
[HTML][HTML] Metastatic recurrence after complete resection of colorectal liver metastases: impact of surgery and chemotherapy on survival
…, T Sprenger, T Lorf, M Niessner, CO Sahlmann… - International journal of …, 2013 - Springer
Purpose Surgery is the standard of care for resectable colorectal liver metastases (CRC-LM).
Unfortunately, 60 % of patients develop secondary metastatic recurrence (SMR) after R0-…
Unfortunately, 60 % of patients develop secondary metastatic recurrence (SMR) after R0-…